Affiliate disclosure: As an Amazon Associate, this site earns from qualifying purchases linked in this article.
Ready to buy? Check current prices on Amazon and compare deals before you decide.
Many women experience vaginal dryness and discomfort as they navigate menopause. These changes are often part of genitourinary syndrome of menopause (GSM), a common condition resulting from declining estrogen levels [1]. While hormonal therapies are a well-established approach, not everyone can or chooses to use them.
Fortunately, a range of non-hormonal treatments can help manage these symptoms, offering relief and supporting vaginal health. Understanding these options can empower women to find what works best for their individual needs and preferences.
Understanding Genitourinary Syndrome of Menopause (GSM)
Genitourinary Syndrome of Menopause (GSM) is a collective term for various symptoms and signs related to the vulva, vagina, and lower urinary tract that occur due to estrogen deficiency during menopause[1][2]. Symptoms can include vaginal dryness, irritation, burning, discomfort during sexual activity (dyspareunia), and sometimes urinary symptoms like urgency, painful urination, and recurrent urinary tract infections [1]. These symptoms can significantly impact quality of life.
The vaginal tissues, urethra, and bladder all have estrogen receptors, and the decline in estrogen can lead to thinning, loss of elasticity, and reduced blood flow in these areas. This can result in changes to the vaginal microbiome and pH, contributing to the discomfort [1]. Recognizing GSM is the first step toward finding appropriate management strategies.
Vaginal Moisturizers: A Foundation of Care
Vaginal moisturizers are a primary non-hormonal approach for managing vaginal dryness and discomfort. These products are designed to be used regularly, typically every few days, to rehydrate and lubricate vaginal tissues[3][4]. They work by adhering to the vaginal lining, releasing water, and helping to restore moisture and elasticity. Unlike lubricants, which are used during sexual activity, moisturizers provide ongoing relief.
Moisturizers often contain ingredients like polycarbophil, hyaluronic acid, or other humectants that draw and hold water in the tissues[3][5]. Consistent use can lead to improvements in vaginal comfort and reduce pain during sexual activity [3]. The AUA/SUFU/AUGS Guideline recommends vaginal moisturizers for individuals with GSM who prefer non-hormonal options or for whom hormonal therapy is not suitable [2].
Vaginal Lubricants: Enhancing Comfort During Intimacy
For immediate relief of discomfort during sexual activity, vaginal lubricants are highly recommended[3][4]. These products are applied just before or during intimacy to reduce friction and increase comfort. Lubricants are available in various formulations, including water-based, silicone-based, and oil-based options. Water-based lubricants are generally safe with condoms and sex toys, while silicone-based lubricants offer longer-lasting slipperiness.
It’s important to choose lubricants that are free from irritants like parabens, glycerin, and harsh preservatives, as these can sometimes exacerbate sensitivity for some individuals. The use of lubricants can significantly improve the experience of intimacy for women experiencing GSM symptoms [3].
Hyaluronic Acid: A Promising Non-Hormonal Option
Hyaluronic acid (HA) is a substance naturally found in the body, known for its ability to retain water. Vaginal formulations of hyaluronic acid have emerged as a notable non-hormonal option for managing GSM symptoms[6][7]. It is available in various forms, including gels, ovules, and suppositories, for vaginal application. Studies suggest that vaginal hyaluronic acid can help improve vaginal dryness, itching, and discomfort, including pain during sexual activity[7][6].
Research indicates that vaginal hyaluronic acid can be effective in improving symptoms associated with vulvovaginal atrophy [7]. A randomized pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for GSM found that hyaluronic acid showed improvements in symptoms [8]. Another study on a medical device containing liposomal hyaluronic acid showed efficacy against vulvo-vaginal dryness [9]. These findings highlight hyaluronic acid as a valuable tool in the non-hormonal management of vaginal discomfort during menopause [3].
Other Non-Hormonal Approaches and Considerations
Beyond moisturizers, lubricants, and hyaluronic acid, other non-hormonal strategies can contribute to vaginal comfort. Regular sexual activity, with or without a partner, can help maintain blood flow and elasticity in vaginal tissues [4]. Avoiding irritants in soaps, detergents, and feminine hygiene products is also important, as these can disrupt the delicate vaginal environment and worsen symptoms [4].
For some individuals, specific prescription non-hormonal medications may be considered. Ospemifene, a selective estrogen receptor modulator (SERM), is an oral medication that works on estrogen receptors in vaginal tissue to help improve elasticity and reduce discomfort[10][3]. It is considered a non-hormonal treatment as it is not an estrogen. Ospemifene is an option for women with moderate to severe GSM symptoms, particularly those for whom vaginal estrogen is not appropriate or desired [10].
While not universally applicable, some women explore complementary therapies. However, it is crucial to discuss any such approaches with a healthcare provider to ensure they are safe and appropriate. Always prioritize evidence-based options and professional medical guidance.
References
- The Genitourinary Syndrome of Menopause: An Overview of the Recent Data. Cureus, 2020
- The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. The Journal of urology, 2025
- Non-hormonal treatments for managing vulvovaginal atrophy/genitourinary syndrome of menopause. Climacteric : the journal of the International Menopause Society, 2023
- Treatment of the genitourinary syndrome of menopause. Climacteric : the journal of the International Menopause Society, 2015
- Updates on Therapeutic Alternatives for Genitourinary Syndrome of Menopause: Hormonal and Non-Hormonal Managements. Journal of menopausal medicine, 2021
- Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review. Climacteric : the journal of the International Menopause Society, 2021
- Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review. The journal of sexual medicine, 2021
- A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause. Menopause (New York, N.Y.), 2024
- [Efficacy of a medical device containing liposomal hyaluronic acid against vulvo-vaginal dryness]. Gynecologie, obstetrique & fertilite, 2015
- Ospemifene for Genitourinary Syndrome of Menopause: Patient Selection. International journal of women’s health, 2024
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
